We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended fifteen drugs for approval at its first meeting of the year, including four generics and one biosimilar.